Development of nitrosyl ruthenium complex-loaded lipid carriers for topical administration: improvement in skin stability and in nitric oxide release by visible light irradiation

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 4, 2010, Pages 843-851

  Marquele Oliveira, Franciane ^a   de Almeida Santana, Danielle Cristine ^a   Taveira, Stephânia Fleury ^a   Vermeulen, Deise Mirella ^a   Moraes de Oliveira, Anderson Rodrigo ^a   da Silva, Roberto Santana ^a   Lopez, Renata Fonseca Vianna ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Nanostructured lipid carriers; Nitrosyl ruthenium complexes; NO photorelease; Solid lipid nanoparticles

Indexed keywords

NANOCARRIER; NITRIC OXIDE; NITROSYLRUTHENIUM COMPLEX; RUTHENIUM COMPLEX; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; EMULSION; FREEZE DRYING; MELANOMA CELL; NANOENCAPSULATION; NONHUMAN; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STORAGE TEMPERATURE; SUSTAINED DRUG RELEASE; SWINE; THERMOSTABILITY; VALIDITY; ZETA POTENTIAL;

ADMINISTRATION, TOPICAL; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG STABILITY; LIGHT; LIPIDS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NITRIC OXIDE; NITRIC OXIDE DONORS; PHOTOCHEMISTRY; RUTHENIUM COMPOUNDS; SKIN NEOPLASMS; SWINE;

EID: 77955586012     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.06.007     Document Type: Article

References (44)

1. Ignarro L.J. Nitric Oxide: Biology and Pathobiology 2000, Academic Press, San Diego. first ed.
2. Rose M.J., Mascharak P.K. Photoactive ruthenium nitrosyls: effects of light and potential application as NO donors. Coord. Chem. Rev. 2008, 252:2093-2114.
3. Thatcher G.R.J. An introduction to NO-related therapeutic agents. Curr. Top. Med. Chem. 2005, 5:597-601.
4. Butler A.R., Megson I.L. Non-heme iron nitrosyls in biology. Chem. Rev. 2002, 102:1155-1166.
5. Mocellin S., Bronte V., Nitti D. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med. Res. Rev. 2007, 27:317-352.
6. Simeone A.M., Colleta S., Krahe R., Jhnson M.M., Mora E., Tari A.M. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells. Carcinogenisis 2006, 27:568-577.
7. +)(terpy)]Cl. Dalton Trans. 2005, 7:1176-1187.
8. -): modulation of the release of NO by the trans-effect. Inorg. Chim. Acta 2005, 358:2883-2890.
9. Bonaventura D., Oliveira F.S., Togniolo V., Tedesco A.C., da Silva R.S., Bendhack L.M. A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation. Nitric Oxide 2004, 10:83-91.
10. Togniolo V., da Silva R.S., Tedesco A.C. Photo-induced nitric oxide release from chlorobis(2,2'-bipyridine)nitrosylruthenium(II) in aqueous solution. Inorg. Chim. Acta 2001, 316:7-12.
11. Oliveira F.D., Togniolo V., Pupo T.T., Tedesco A.C., da Silva R.S. Nitrosyl ruthenium complex as nitric oxide delivery agent: synthesis, characterization and photochemical properties. Inorg. Chem. Commun. 2004, 7:160-164.
12. Sauaia M.G., Oliveira F.S., Tedesco A.C., da Silva R.S. Control of NO release by light irradiation from nitrosyl-ruthenium complexes containing polypyridyl ligands. Inorg. Chim. Acta 2003, 355:191-196.
13. Sauaia M.G., de Lima R.G., Tedesco A.C., da Silva R.S. Photoinduced NO release by visible light irradiation from pyrazine-bridged nitrosyl ruthenium complexes. J. Am. Chem. Soc. 2003, 125:14718-14719.
14. Sauaia M.G., Oliveira F.S., de Lima R.G., Cacciari A.D.L., Tfouni E., da Silva R.S. Syntheses, characterization and photochemical properties of new NO-ruthenium(II) complexes. Inorg. Chem. Commun. 2005, 8:347-349.
15. 3+ complex and its vasodilator activity based on visible light irradiation. Inorg. Chim. Acta 2006, 359:2543-2549.
16. de Lima R.G., Sauaia M.G., Feresin C., Pepe I.M., José N.M., Bendhack L.M., da Rocha Z.N., da Silva R.S. Photochemical and pharmacological aspects of nitric oxide release from some nitrosyl ruthenium complexes entrapped in sol-gel and silicone matrices. Polyhedron 2007, 26:4620-4624.
17. Bonaventura D., De Lima R.G., Vercesi J.A., da Silva R.S., Bendhack L.M. Comparison of the mechanisms underlying the relaxation induced by two nitric oxide donors: sodium nitroprusside and a new ruthenium complex. Vasc. Pharmacol. 2007, 46:215-222.
18. de Lima R.G., Sauaia M.G., Bonaventura D., Tedesco A.C., Lopez R.F.V., Bendhack L.M., da Silva R.S. Controlled nitric oxide photo-release from nitro ruthenium complexes: the vasodilator response produced by UV light irradiation. Inorg. Chim. Acta 2005, 358:2643-2650.
19. 3(NO)(dppf)], dppf=1,1'-bis(diphenylphosphine)ferrocene. Polyhedron 2007, 26:4707-4712.
20. de Oliveira A.R.M., Marquele-Oliveira F., de Santana D.C.A.S., Nikolaou S., Bonato P.S., da Silva R.S. HPLC separation, NMR and QTOF/MS/MS structure elucidation of a prominent nitric oxide donor agent based on an isomeric composition of a nitrosyl ruthenium complex. Inorg. Chem. Commun. 2009, 12:343-346.
21. 3+ nitric oxide donor using rat microsomes. Nitric Oxide 2009, 21:14-19.
22. Vallance P., Collier J. Fortnightly review biology and clinical relevance of nitric oxide. Br. Med. J. 1994, 309:453-457.
23. Schäfer-Korting M., Mehnert W., Korting H.C. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 2000, 59:427-443.
24. Taviera S.F., Nomizo A., Lopez R.F.V. Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity. J. Control. Release 2009, 134:35-40.
25. Müller R.H., Radtke M., Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermal dermatological preparations. Adv. Drug Deliv. Rev. 2002, 54(Suppl. 1):S131-S155.
26. Müller R.H. Lipid nanoparticles: recent advances. Adv. Drug Deliv. Rev. 2007, 59:375-376.
27. 10: development, physicochemical characterization and in vitro release studies. Eur. J. Pharm. Biopharm. 2007, 67:141-148.
28. Shah K.A., Date A.A., Joshi M.D., Patravale V.B. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int. J. Pharm. 2007, 345:163-171.
29. Sivaramakrishnan R., Nakamura C., Mehnert W., Korting H.C., Kramer K.D., Schäfer-Korting M. Glucocorticoid entrapment into lipid carriers - characterisation by parelectric spectroscopy and influence on dermal uptake. J. Control. Release 2004, 97:493-502.
30. Maia C.S., Mehnert W., Schäfer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int. J. Pharm. 2000, 196:165-167.
31. Wong H.L., Bendayan R., Rauth A.M., Wu X.Y. Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers. J. Pharm. Sci. 2004, 93:1993-2008.
32. Ruckmani K., Sivakumar M., Gebeshkumar P.A. Methotrexate loaded solid lipid nanoparticles (SLN) for effective treatment of carcinoma. J. Nanosci. Nanotechnol. 2006, 6:2991-2995.
33. FDA Guidance for Industry Bioanalytical Method Validation 2001, Center for Drug Evaluation and Research. http://www.fda.gov/cder/guidance/4252fnl.fdf.
34. Pattani A.S., Manawgade S.D., Patravale V.B. Development and comparative anti-microbial evaluation of lipid nanoparticles and nanoemulsion of polymyxin B. J. Nanosci. Nanotechnol. 2006, 6:1-5.
35. 2+ as nitric oxide donor. Trends Inorg. Chem. 2008, 10:27-34.
36. Ugazio E., Cavalli R., Gasco M.R. Incorporation of cyclosporine A in solid lipid nanoparticles (SLN). Int. J. Pharm. 2002, 241:341-344.
37. Saupe A., Wissing S., Lenk A., Schmidt C., Müller R.H. Solid lipid nanoparticles (SLN) and nanoestructured lipid carriers (NLC) - structural investigations on two different carriers systems. Biomed. Mater. Eng. 2005, 15:393-402.
38. Tiyaboonchai W., Tungpradit W., Plianbangchang P. Formulation and characterrization of curcuminoids loaded solid lipid nanaoparticles. Int. J. Pharm. 2007, 337:299-306.
39. Müller R.H., Mäder K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 2000, 50:161-177.
40. Yuan H., Wang L.L., Du Y.Z., You J., Hu F.Q., Zeng S. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surf. B 2007, 60:174-179.
41. Joshi M., Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int. J. Pharm. 2008, 346:124-132.
42. Thomas D.D., Ridnou L.A., Isenberg J.S., Flores-Santana W., Switzer C.H., Donzelli S., Hussain P., Vecoli C., Paolocci N., Ambs S., Colton C.A., Harris C.C., Roberts D.D., Wink D.A. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic. Biol. Med. 2008, 45:18-31.
43. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 1999, Pergamon Press, New York. third ed.
44. Weichenthal M., Schwarz T.T. Phototherapy: how does UV work?. Photodermatol. Photoimmunol. Photomed. 2005, 21:260-266.